Thanks
@DickyB
I just spoke with TK and he is very happy with the progress at Medgate, both at a technical level and empowering clinicians within the Medgate system. Tony made the comment that he is 'gobsmacked' with the market's reaction with the SP. Similarily with Ilara, field evaluation is encouraging and he is happy with progress. There are no negatives that I heard from him. Obviously though he would only give me positives.
UK and European clinical trials have been ground to a halt with COVID; it is not just with us, but most or all clinical trials withn the health systems over there.
I asked about the frustration of the BOD buying shares, it has been discussed many times at Board level, and presently there is a blockout period. I sensed that TK was a little frustrated with this, but that was just my impression, not fact.
I am not attempting to upramp, just reporting in on what I heard.
